
Caught up with @drsarahsam before her Oral Discussion today at #ASCO26 @UMGCCC
✓Medical Oncologist @UMGCCC, Associate Director for Clinical Research, Solid Tumor Section Head, Director Head and Neck Oncology, opinions my own

Caught up with @drsarahsam before her Oral Discussion today at #ASCO26 @UMGCCC

WATCH 👀: @RaneeMehra of @UMMC discusses @US_FDA breakthrough therapy designation for amivantamab in HNSCC. See the whole video here ➡️: hubs.li/Q044M2hF0 #hncsm #oncology

Appreciated the opportunity to present this data on behalf of my co- authors @UMGCCC

How will emerging immunotherapy strategies shape care for patients with R/M #HNSCC? Join me, Barbara Burtness, MD and @AartiBhatiaMD for a @PeerView live symposium at #MHNCS26 on 2/19 at12:30 PM PST. Attend in Palm Desert or virtually! bit.ly/MHNCS26-T @UMGCCC

To close out #Appendix Cancer Awareness Month.. Read more about it and hear from our expert Dr. Benjamin Powers @UMGCCC. webmd.com/cancer/appendix-ca… @acpmpresearch @MarylandSurg

On Saturday at #ASCO25, UMGCCC physician-scientists shared research and made connections with national oncology leaders. Check out Dr. Radhakrishnan’s poster on the impact of time to neoadjuvant treatment initiation in non-small cell lung cancer patients: ow.ly/5PBf50W23os

New paper in @CCR_AACR from Drs. @Sam_Rosner_ , @kamarroneMD and @SmithImmunology @hopkinsthoracic analyzing outcomes by KRAS + STK11 mutation status in pts treated with neoadjuvant IO for lung ca! #lcsm @KRASKickers @LUNGevity aacrjournals.org/clincancerr…

The cover of @CEBP_AACR features a graphic adapted from a new study by @kathrynhbarry1 linking neighborhood disadvantage, racial segregation and historical redlining with increased risk of aggressive prostate cancer, particularly in African-American men. umms.com/3BMOm76

So excited to get to work to further understand the basis for survival disparities in oral cavity cancer with our newly funded MPI R01. Grateful to have such a wonderful team! @GaykalovaLab @UMGCCC @UMBaltimore @JKMolitoris Lei Ren

Small cell lung cancer is an aggressive cancer with poor overall survival and limited treatment options. Our executive director, Dr. Taofeek Owonikoko (@teekayowo), is playing a significant role in several clinical trials to investigate new drug therapies for SCLC. #ASCO24.

Patients with HPV-linked throat cancer who had transoral surgery + reduced post-operative radiation, experienced favorable 54-month progression-free & overall survival, research presented at #ASCO24 found. UMGCCC researchers co-authored the potentially practice-informing study.

At the core of our mission to save countless lives from cancer is a steadfast dedication to clinical and basic research, resulting in better treatments and improved outcomes. #NationalCancerResearchMonth

Please join us for the Maryland Half Marathon & 5K. The signature community event to benefit @UMGCCC Whether a runner, walker or just there to cheer others on, we look forward to seeing you there @UMBaltimore @umms @UMMSFoundation @UMmedschool @FOXBaltimore @Ravens @Orioles

Lead investigator Dr. Jason Molitoris @JKMolitoris reports on outcomes & de-escalating treatment for HPV–associated oropharynx squamous cell carcinoma #headandneckcancer #hncsm medscape.com/viewarticle/de-…

Great work by Jessica Krc. Genomic profile of patients undergoing re-irradiation. @MatthewWitekMD @UMGCCC @UMarylandRadOnc #HNCS24

Great presentation by Jason Molitoris discussing results of our Saver trial Contralateral de-escalation of p16+ OPC #HNCS24 @UMGCCC @MatthewWitekMD @HattenMD @UMarylandRadOnc